Hong Kong-listed biopharmaceutical stocks rallied in the afternoon, with Ascletis Pharma (01672.HK) surging over 9%, and other stocks such as BeiGene (06160.HK), CSPC Pharmaceutical Group (01093.HK), Akeso Biopharma (09926.HK), and Innovent Biologics (09969.HK) following suit.